0001179110-21-010095.txt : 20211112
0001179110-21-010095.hdr.sgml : 20211112
20211112161531
ACCESSION NUMBER: 0001179110-21-010095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211109
FILED AS OF DATE: 20211112
DATE AS OF CHANGE: 20211112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Veness Adam M
CENTRAL INDEX KEY: 0001778623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 211403670
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-11-09
0
0001280600
ACCELERON PHARMA INC
XLRN
0001778623
Veness Adam M
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP, General Counsel and Sec.
Common Stock
2021-11-09
4
M
0
4500
29.37
A
23423
D
Option to Purchase Common Stock
29.37
2021-11-09
4
M
0
4500
0
D
2024-08-01
Common Stock
4500
0
D
The shares of common stock underlying this stock option award vested as to 25% of the shares on July 14, 2015 and the remaining shares vested in equal quarterly installments over the following three years thereafter.
/s/ Adam M. Veness
2021-11-12